Reduced reperfusion-induced Ins(1,4,5)P3 generation and arrhythmias in hearts expressing constitutively active α(1B)-adrenergic receptors

Circulation Research

Volumn 83, Issue 12, 1998, Pages 1232-1240

  Harrison, Sharon N ^a   Autelitano, Dominic J ^a   Wang, Bing Hui ^a   Milano, Carmelo ^b   Du, Xiao Jun ^a   Woodcock, Elizabeth A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arrhythmia; Ins(1,4,5)P3; Reperfusion; (1A) adrenergic receptor; (1B) adrenergic receptor

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; INOSITOL TRISPHOSPHATE;

ANIMAL TISSUE; ARTICLE; HEART ARRHYTHMIA; HEART MUSCLE PERFUSION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0032576553     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.12.1232     Document Type: Article

References (47)

1. 1-adrenergic stimulation in cardiac myocytes exposed to ischaemia. J Clin Invest. 1989;83:1409-1413.
2. Pogwizd S, Corr P. Biochemical and electrophysiological alterations underlying ventricular arrhythmias in the failing heart. Eur Heart J. 1994;15:145-154.
3. 1-Adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther. 1988;247:1039-1045.
4. Sheridan DJ. Alpha adrenoceptors and arrhythmias. J Mol Cell Cardiol. 1986;18:59-68.
5. Woodcock E, Suss M, Anderson K. Inositol phosphate release and metabolism in rat left atria. Circ Res. 1995;76:252-260.
6. Kijima Y, Saito A, Jetton TL, Magnuson MA, Fleischer S. Different intracellular localization of inositol 1,4,5-trisphosphate and ryanodine receptors in cardiomyocytes. J Biol Chem. 1993;268:3499-3506.
7. Gorza L, Schiaffino S, Volpe P. Inositol 1.4,5-trisphosphate receptor in heart: evidence for its concentration in Purkinje myocytes of the conduction system. J Cell Biol. 1993;121:345-353.
8. 3. Am J Physiol. 1990;258: H610-H615.
9. 2+ release from cardiac sarcoplasmic reticulum. Pflugers Arch. 1991;418:1-6.
10. Anderson K, Dart A, Woodcock E. Inositol phosphate release and metabolism during myocardial ischemia and reperfusion in rat heart. Circ Res. 1995;76:261-268.
11. 3 release. Circulation. 1995;91:2712-2716.
12. Jacobsen AN, Du XJ, Lambert KA, Dart AM, Woodcock EA. Arrhythmogenic action of thrombin during myocardial reperfusion via release of inositol 1,4,5-triphosphate. Circulation. 1996;93:23-26.
13. Lomasney JW, Cotecchia S, Lefkowitz RJ, Caron MG. Molecular biology of α-adrenergic receptors: implications for receptor classification and for structure function relationships. Biochim Biophys Acta. 1991;1095: 127-139.
14. 1-adrenoceptor subtypes in rat heart. Br J Pharmacol. 1994;111: 533-538.
15. 1-adrenoreceptor subtypes to phospholipase C and mitogen activated protein kinase in neonatal rat cardiac myocytes. Eur J Pharmacol. 1997;339:77-86.
16. 1C. Biochem Biophys Res Commun. 1994;201:1296-1304.
17. 1-Adrenergic receptor signaling via G(h) is subtype specific and independent of its transglutaminase activity. J Biol Chem. 1996;271: 32385-32391.
18. 1A-adrenoceptor antagonist, inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart. Eur J Pharmacol. 1996;312:281-291.
19. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem. 1993;268:15374-15380.
20. 1C. J Biol Chem. 1996;271:5839-5843.
21. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci USA. 1990;87:2896-2900.
22. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA. 1994;91:10109-10113.
23. Eisenhofer G, Goldstein D, Stull R, Keiser H, Sunderland T, Murphy D, Kopin I. Simultaneous liquid-chromatographic determination of 3,4-dihydrophenolglycol, catecholamines and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem. 1986;32:2030-2033.
24. Woodcock EA. Analysis of inositol phosphates in heart tissue using anion-exchange high-performance liquid chromatography. Mol Cell Biochem. 1997;172:121-127.
25. Divecha N, Banfic H, Irvine RF. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase-C to the nucleus. EMBO J. 1991;10:3207-3214.
26. Chomczynsky P, Sacchi N. Single-step method of RNA by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162:156-159.
27. 1A-subtype. Mol Pharmacol. 1994;46:414-422.
28. 1-adrenergic receptor. Proc Natl Acad Sci USA. 1988;85:7159-7163.
29. Autelitano D, Blum M, Roberts J. Changes in rat pituitary nuclear and cytoplasmic pro-opiomelanocortin RNAs associated with adrenalectomy and glucocorticoid replacement. Mol Cell Endocrinol. 1989;119:25-35.
30. Sato A, Canny B, Autelitano D. Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in caridomyocytes. Biochem Biophys Res Commun. 1997;230:311-314.
31. 2-adrenergic receptor. Am J Physiol. 1996;40:H630-H636.
32. Harada K, Komuro I, Hayashi D, Sugaya T, Murakami K, Yazaki Y. Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation. 1998;97:315-317.
33. Walker M, Curtis M, Hearse D, Campbell R, Janse M, Yellon D, Cobbe S, Coker S, Harness J, Harron D, Higgens A, Julian D, Lab M, Manning A, Northover B, Parratt J, Reimersma R, Riva E, Russell D, Sheridan D, Winslow E, Woodward B. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res. 1988;22:447-455.
34. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM. Myocardial ischemia and reprefusion: a murine model. Am J Physiol. 1995;269:H2147-H2154.
35. Woodcock E, Lambert K, Phan T, Jacobsen A. Inositol phosphate metabolism during myocardial ischemia. J Mol Cell Cardiol. 1997;29: 449-460.
36. 1A-adrenoceptors in rabbits. J Cardiovasc Pharmacol. 1997;30:437-445.
37. Schomig A. Catecholamines in myocardial ischemia. Circulation. 1990; 82(suppl II):II-13-II-22.
38. 1-Receptor-independent activation of protein kinase C in acute myocardial ischemia: mechanism for sensitization of the adenylyl cyclase system. Circ Res. 1992;70:1304-1312.
39. + exchanger: evidence for a receptor-mediated mechanism involving protein kinase C. Circ Res. 1996;79:705-715.
40. Felzen B, Shilkrut M, Less H, Saparov I, Coleman R, Robinson R, Berke G, Binah O. Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perform gene-knockout mice: involvement of inositol trisphosphate. Circ Res. 1998;82:438-450.
41. Anderson KE, Woodcock EA. Preconditioning of perfused rat heart inhibits reperfusion-induced release of inositol(1,4,5)trisphosphate. J Mol Cell Cardiol. 1995;27:2421-2431.
42. 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation. 1995;92:2259-2265.
43. 1-adrenergic receptor subtype mRNAs. J Mol Cell Cardiol. 1998;30:1515-1523.
44. 1-adrenergic receptor subtype. Circulation. 1991;83:2076-2082.
45. Geller JC, Cua M, Prieto L, Guo SD, Danilo P, Rosen MR. Chloroethylclonidine increases the incidence of lethal arrhythmias during coronary occlusion in anesthetized dogs. Eur J Pharmacol. 1995;294:423-428.
46. 1-adrenergic stimulation: a potential role for receptor mediated activation of sarcolemmal sodium-hydrogen exchange. Cardiovasc Res. 1995;29:222-230.
47. 1A-adrenoceptor antagonists on reperfusion arrhythmias in isolated rat hearts. Mol Cell Biochem. 1995;147:173-180.